Optovue Stock

optovue.comHealthcareFounded: 2003Funding to Date: $44.77MM

Optovue is a medical device company focused on developing the next generation of ophthalmic optical coherence tomography (OCT) instruments.

Register for Details

For more details on financing and valuation for Optovue, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Jay Wei
Chief Executive Officer, Founder and President
David Voris
President & Chief Financial Officer
Dragos Stanescu
Director, Mechanical Engineering
Larry Alexander
Senior Director, Clinical Education

Other companies like Optovue in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$263MM

News

FREMONT, Calif.—Optovue, Inc., a global leader in the development and commercialization of optical coherence tomography (OCT) and OCT angiography technology for the eyecare market, announced it has executed an agreement to receive $30 million in private equity funding from Deltronics (Netherlands) B.V., a subsidiary of Taiwan-based Delta Electronics, Inc., a global leader in power and thermal management solutions.